BuzzSparks.org

Versant Ventures


Venture capital Firm

Versant Ventures is a leading healthcare-focused venture capital firm specializing in early-stage investments in medical devices, biotechnology and pharmaceuticals, healthcare services, and healthcare information technology. The firm, founded in...

Founded in 1999
Employees: 12
Homepage:

94025 3000 Sand Hill Road, Bldg 4
Suite 210

Menlo Park
USA CA

Phone: (650) 233-7877

Updated on Jun 3, 2009
Versant Ventures at CrunchBase
Samuel D. Colella Managing Director, Co-Founder
Donald B. Milder Managing Director, Co-Founder
Brian Atwood Co-Founder
Robin L. Praeger CFO
Ross A. Jaffe MD
Barbara Lubash Managing Director, Co-Founder
Camille Samuels Managing Director
Kevin Wasserstein Managing Director
Bobak Azamian Investment Professionals
Alicia Levey Investment Professionals
Mike Rosenbluth Investment Professionals
Scott Chetham Venture partner & Advisor
Stephen Kaldor Venture partner & Advisor
Thomas Woiwode Venture partner & Advisor
William Link Managing Director, Co-Founder
Bradley Bolzon Managing Director
Charles Warden Managing Director
Rebecca Robertson Managing Director
Jerel Davis Investment Professionals
Carlo Rizzuto Investment Professionals
Jim Mazzo Venture partner & Advisor
Gianni Gromo Venture partner & Advisor
Guido Magni Venture partner & Advisor
Past
Kirk G. Nielsen sales representative
Shay Hassidim Lead Architect – VDS GUI tools , Technical Manager - Versant Israe

July, 2013

Versant Ventures invested $30M in Audentes Therapeutics as a Series A round

June, 2013

Versant Ventures invested $28M in Veracyte as a Series C round

April, 2013

Versant Ventures invested $43.2M in GenSight Biologics as a Series A round

March, 2013

Versant Ventures invested $8M in Theraclone Sciences as a Series B round

Versant Ventures invested $7.5M in Novira Therapeutics as a Series A round

February, 2013

Versant Ventures invested $10M in Innovative Pulmonary Solutions as a Series C round

Versant Ventures invested $30M in Glaukos as a Series F round

January, 2013

Versant Ventures invested $23.8M in Ocular Therapeutix as a Series D round

Versant Ventures invested $19.5M in Ceterix Orthopaedics as a Series B round

December, 2012

Versant Ventures invested $20M in Flexion Therapeutics as a Series B round

November, 2012

Versant Ventures invested $37.3M in CardiAQ Valve Technologies as a Series B round

October, 2012

Versant Ventures invested $5.9M in Cerephex as a Series A round

September, 2012

Versant Ventures invested $10.6M in Innovative Pulmonary Solutions as unattributed round

Versant Ventures invested $6M in ROX Medical as unattributed round

August, 2012

Versant Ventures invested $10M in Alter-G as a Series C round

June, 2012

Versant Ventures invested $25M in Benvenue Medical as a Series D round

May, 2012

Versant Ventures invested $25M in Zyga Technology as a Series C round

March, 2012

Versant Ventures invested $17M in OpGen as unattributed round

Versant Ventures invested $26M in Sequent Medical as a Series C round

December, 2011

Versant Ventures invested $6M in Groove Biopharma as a Series B round

November, 2011

Versant Ventures invested $8M in Advanced ICU Care as a Series D round

Versant Ventures invested $65M in AcuFocus as a Series F round

September, 2011

Versant Ventures invested $37.4M in Kythera Biopharmaceuticals as a Series D round

August, 2011

Versant Ventures invested $12M in Intuity Medical as a Series D round

May, 2011

Versant Ventures invested $15.9M in WaveTec Vision as a Series D round

April, 2011

Versant Ventures invested $35.5M in Benvenue Medical as a Series C round

January, 2011

Versant Ventures invested $3M in Augmenix as debt_round round

October, 2010

Versant Ventures invested $30M in Synosia Therapeutics as a Series C round

September, 2010

Versant Ventures invested $17M in OpGen as a Series B round

Versant Ventures invested $20.5M in Okairos as a Series B round

July, 2010

Versant Ventures invested $32M in Immune Design as a Series B round

June, 2010

Versant Ventures invested $28M in Veracyte as a Series B round

May, 2010

Versant Ventures invested $15.6M in Sequent Medical as a Series B round

April, 2010

Versant Ventures invested $3.9M in Mirina as a Series A round

January, 2010

Versant Ventures invested $64M in Intuity Medical as a Series D round

November, 2009

Versant Ventures invested $7.5M in Fluidigm as unattributed round

Versant Ventures invested $8.6M in Metabolex as unattributed round

October, 2009

Versant Ventures invested $6.1M in Augmenix as a Series B round

Versant Ventures invested $33M in Flexion Therapeutics as a Series A round

June, 2009

Versant Ventures invested $15M in Ocular Therapeutix as a Series C round

Versant Ventures invested $9.4M in Transcend Medical as a Series A round

Versant Ventures invested $13M in Anaphore as a Series A round

May, 2009

Versant Ventures invested $145M in Clovis Oncology as a Series A round

April, 2009

Versant Ventures invested $15M in RedBrick Health as a Series C round

Versant Ventures invested $10M in Ambrx as a Series D round

March, 2009

Versant Ventures invested $22.4M in LensX Lasers as a Series B round

Versant Ventures invested $12.3M in Rennovia as a Series A round

January, 2009

Versant Ventures invested $8M in Alter-G as a Series B round

Versant Ventures invested $29M in Synosia Therapeutics as a Series B round

October, 2008

Versant Ventures invested $21M in Cardiac Concepts as a Series B round

September, 2008

Versant Ventures invested $32M in APT Pharmaceuticals as a Series A round

Versant Ventures invested $22.5M in Microfabrica as a Series B round

August, 2008

Versant Ventures invested $35M in Glaukos as a Series D round

July, 2008

Versant Ventures invested $18M in Immune Design as a Series A round

June, 2008

Versant Ventures invested $9M in Vaccsys as unattributed round

May, 2008

Versant Ventures invested $30M in Kythera Biopharmaceuticals as a Series C round

Versant Ventures invested $49.5M in NovaSys as unattributed round

April, 2008

Versant Ventures invested $8M in Anaphore as unattributed round

March, 2008

Versant Ventures invested $14M in Cameron Health as a Series E round

February, 2008

Versant Ventures invested $19M in PhaseRx as a Series A round

January, 2008

Versant Ventures invested $15M in Benvenue Medical as a Series B round

September, 2007

Versant Ventures invested $23.6M in OpGen as a Series A round

April, 2007

Versant Ventures invested $32M in Metabolex as a Series D round

January, 2007

Versant Ventures invested $17M in Fluidigm as a Series E round

Versant Ventures invested $32.5M in Synosia Therapeutics as unattributed round

December, 2006

Versant Ventures invested $41M in NeoVista as a Series C round

November, 2006

Versant Ventures invested $5M in Impedance Cardiology Systems as a Series B round

Versant Ventures invested $35M in Neurotech as a Series B round

October, 2006

Versant Ventures invested $26M in Achaogen as a Series B round

September, 2006

Versant Ventures invested $26M in NeoVista as a Series B round

July, 2006

Versant Ventures invested $30M in Kythera Biopharmaceuticals as a Series B round

Versant Ventures invested $11M in Pathwork Diagnostics as unattributed round

April, 2006

Versant Ventures invested $10.8M in MedManage Systems as a Series D round

September, 2005

Versant Ventures invested $1M in Kythera Biopharmaceuticals as unattributed round

February, 2005

Versant Ventures invested $45M in Five Prime Therapeutics as unattributed round

September, 2002

Versant Ventures invested $10M in Glaukos as a Series A round

1999

Versant Ventures was founded in 1999